Tenax Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Chapel Hill, NC
TENX chart
What traders are saying about $TENX
Latest postsTenax Therapeutics, Inc. news
- Tenax Therapeutics faces class action lawsuit o...
Pluang ·
- TENX INVESTOR ALERT: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead the Tenax Therapeutics Class Action Lawsuit – RGRD Law
lincolnjournal.com ·
- TENX INVESTOR ALERT: Tenax Therapeutics, Inc. Investors
GlobeNewswire ·
- BlackRock reports a passive stake in Tenax Therapeutics (TENX), with sole votes on 2.75M shares.
Stock Titan ·
- Class action lawsuit filed against Tenax Therap...
Pluang ·
- Investor Alert: Deadline Approaching to Join Tenax Therapeutics, Inc. (TENX) Class Action - Contact Levi & Korsinsky
ACCESS Newswire ·
- Investor Alert: Robbins LLP Informs Investors of the Tenax Therapeutics, Inc. Class Action Lawsuit
FinancialContent ·
- Tenax Therapeutics Securities Class Action (TENX)
openclassactions.com ·
- Tenax Therapeutics (TENX) Stock Fair Value Falls After Cautious Analyst Calls On LEVEL Data
Yahoo Finance ·
- Tenax Therapeutics, Inc. Estimates – NASDAQ:TENX
TradingView ·
- Form 4 Tenax Therapeutics Inc: ADAR1 Capital Management, LLC (10% Owner) For: 19 October
Investing.com Nigeria ·
- Adar1 Capital Management, a 10% owner, buys $1.46m of Tenax Therapeutics
Investing.com ·
Tenax Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | – | – |
| Net income | -$52.6M | -$17.6M | -$7.7M | $11.0M |
| Diluted EPS | $-1.34 | $-1.15 | $-31.04 | – |
| Total assets (year end) | $104.2M | $96.7M | $11.7M | $3.4M |
| Cash and equivalents (year end) | $97.6M | $94.9M | $9.8M | $2.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tenax Therapeutics, Inc.
- Ticker
- TENX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Chapel Hill, NC
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 34956
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
Frequently asked questions
What exchange is Tenax Therapeutics, Inc. listed on?
Tenax Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TENX.
What industry is Tenax Therapeutics, Inc. in?
Tenax Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Tenax Therapeutics, Inc. headquartered?
Tenax Therapeutics, Inc.'s business address on file with the SEC is in Chapel Hill, NC.
When does Tenax Therapeutics, Inc.'s fiscal year end?
Tenax Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Tenax Therapeutics, Inc. report?
Tenax Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.